| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
8,798,000 |
| Market
Cap: |
37.74(M) |
| Last
Volume: |
9,790 |
Avg
Vol: |
9,763 |
| 52
Week Range: |
$0.8414 - $8.78 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Marker Therapeutics is a clinical-stage immuno-oncology company focusing on the development of T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. Co. is developing three product candidates as part of its multi tumor associated antigen-specific T cell program for: autologous treatment of lymphoma, and selected solid tumors; allogeneic T cells for the treatment of acute myeloid leukemia (AML); and off-the-shelf products in various indications. Co.'s clinical development programs are: MT-401 for the treatment of post-transplant AML; MT-401-OTS for the treatment of AML; and MT-601 for the treatment of lymphoma.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Hoang Peter L. |
President and CEO |
• • – |
2022-03-24 |
4 |
D |
$0.48 |
$23,453 |
D/D |
(48,376) |
483,286 |
|
- |
|
| Hoang Peter L. |
President and CEO |
• • – |
2022-03-24 |
4 |
A |
$0.00 |
$0 |
D/D |
199,094 |
531,662 |
|
- |
|
| Vera Juan |
Chief Scientific Officer & COO |
• • – |
2022-03-24 |
4 |
D |
$0.48 |
$16,224 |
D/D |
(33,465) |
2,671,845 |
|
- |
|
| Vera Juan |
Chief Scientific Officer & COO |
• • – |
2022-03-24 |
4 |
A |
$0.00 |
$0 |
D/D |
140,823 |
2,705,310 |
|
- |
|
| Kim Anthony H. |
Chief Financial Officer |
• – – |
2022-03-24 |
4 |
D |
$0.48 |
$17,490 |
D/D |
(36,076) |
114,436 |
|
- |
|
| Kim Anthony H. |
Chief Financial Officer |
• – – |
2022-03-24 |
4 |
A |
$0.00 |
$0 |
D/D |
150,512 |
150,512 |
|
- |
|
| Knobil Katharine |
Director |
– • – |
2021-12-08 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,500 |
|
- |
|
| Eansor N David |
Director |
– • – |
2021-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
12,658 |
36,940 |
|
- |
|
| Wasserman Frederick Gerald |
Director |
– • – |
2021-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
12,658 |
65,223 |
|
- |
|
| Laskow-Pooley David |
Director |
– • – |
2021-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
12,658 |
55,223 |
|
- |
|
| Elms Steve |
Director |
– • – |
2021-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
12,658 |
29,680 |
|
- |
|
| Wilson John Robert |
Director |
– • – |
2021-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
12,658 |
7,812,008 |
|
- |
|
| Wasserman Frederick Gerald |
Director |
– • – |
2021-05-18 |
4 |
B |
$2.41 |
$24,098 |
D/D |
10,000 |
52,565 |
2.39 |
- |
|
| Eansor N David |
Director |
– • – |
2021-03-25 |
4 |
GA |
$0.00 |
$0 |
I/I |
14,284 |
7,142 |
|
- |
|
| Eansor N David |
Director |
– • – |
2021-03-25 |
4 |
GD |
$0.00 |
$0 |
D/D |
14,285 |
2,428 |
|
- |
|
| Eansor N David |
Director |
– • – |
2021-03-16 |
4 |
B |
$17.50 |
$249,988 |
D/D |
14,285 |
16,713 |
2.39 |
- |
|
| Elms Steve |
Director |
– • – |
2021-03-16 |
4 |
B |
$1.75 |
$2,000,000 |
I/I |
1,142,857 |
3,142,857 |
2.1 |
- |
|
| Sandell Scott D |
10% Owner |
– – • |
2021-03-16 |
4 |
B |
$1.75 |
$9,999,999 |
I/I |
5,714,285 |
10,714,285 |
1.5 |
- |
|
| Wilson John Robert |
Director |
– • – |
2021-03-16 |
4 |
B |
$1.75 |
$2,999,999 |
D/D |
1,714,285 |
7,799,350 |
2.39 |
- |
|
| Makhzoumi Mohamad |
10% Owner |
– – • |
2021-03-16 |
4 |
B |
$1.75 |
$9,999,999 |
I/I |
5,714,285 |
10,714,285 |
1.5 |
- |
|
| Behbahani Ali |
10% Owner |
– – • |
2021-03-16 |
4 |
B |
$1.75 |
$9,999,999 |
I/I |
5,714,285 |
10,714,285 |
1.5 |
- |
|
| Florence Anthony A. Jr. |
10% Owner |
– – • |
2021-03-16 |
4 |
B |
$1.75 |
$9,999,999 |
I/I |
5,714,285 |
10,714,285 |
1.5 |
- |
|
| Hoang Peter L. |
President and CEO |
• • – |
2021-03-16 |
4 |
B |
$1.75 |
$250,000 |
D/D |
142,857 |
332,568 |
2.81 |
- |
|
| Chang Carmen |
10% Owner |
– – • |
2021-03-16 |
4 |
B |
$1.75 |
$9,999,999 |
I/I |
5,714,285 |
10,714,285 |
1.5 |
- |
|
| Vera Juan |
Chief Development Officer |
• – – |
2021-03-16 |
4 |
B |
$1.75 |
$999,999 |
D/D |
571,428 |
2,564,487 |
2.74 |
- |
|
67 Records found
|
|
Page 1 of 3 |
|
|
0.08 (1.72%) 
